Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
Jordi Díaz‐Manera(Newcastle upon Tyne Hospitals NHS Foundation Trust), Tanya Stojkovic(Inserm), Jean‐Yves Hogrel(Institut de Myologie), Bruce Harwick(Carolinas Healthcare System), Simone Spuler(Harvard University), Maggie C. Walter(Ludwig-Maximilians-Universität München), Diana Bharucha‐Goebel(National Institutes of Health), Susana Rico Gala(Hospital Universitario de Valme), Carolina Tesi Rocha(Stanford University), Olivia Schreiber‐Katz(Medizinische Hochschule Hannover), David Bendahan(Aix-Marseille Université), Alan Pestronk(Washington University in St. Louis), Matthew Harms(Lourdes University), Yann Le Fur(Aix-Marseille Université), Kristi Jones(South Australia Pathology), Plavi Mittal(Jain Foundation), Roberto Stramare(University of Padua), Sheryl Foster(The University of Sydney), M. James(Newcastle upon Tyne Hospitals NHS Foundation Trust), Emmanuelle Salort‐Campana(Hôpital de la Timone), Alessandro Rampado(University of Padua), Ulrike Grieben(Max Delbrück Center), Laura Rufibach(Jain Foundation), Sabine Krause(Ludwig-Maximilians-Universität München), Marni Jacobs(Children's National), Hanns Lochmüller(University of Ottawa), Anna Mayhew(Newcastle upon Tyne Hospitals NHS Foundation Trust), Suna Turk(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Mark D. Smith(Nationwide Children's Hospital), Pierre G. Carlier, Michelle Eagle(Newcastle University), Stanley T. Fricke(Children's National), Roberto Fernández‐Torrón(Biogipuzkoa Health Research Institute), Andrew M. Blamire(Newcastle Hospitals - Campus for Ageing and Vitality), H. Hilsden(Muscular Dystrophy UK), Hansel J. Otero, Dorothy Wallace(Newcastle University), Eva Coppenrath(Ludwig-Maximilians-Universität München), Takeshi Tamaru(National Center of Neurology and Psychiatry), Tim Hodgson(Eastman Dental Hospital), Noriko Sato(National Center of Neurology and Psychiatry), Louise Ward(Newcastle University), Anthony Peduto(Westmead Hospital), Fiona E. Smith(Newcastle University), Jaume Llauger(Universitat Autònoma de Barcelona), Glenn Foster, U. Moore(Muscular Dystrophy UK), Anne Marie Sawyer(Stanford University), Carmen Paradas(Instituto de Salud Carlos III)
Cited by 118
Related Papers
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462
Myasthenia Gravis
|New England Journal of Medicine|1977|435
Radiation Dose and Second Cancer Risk in Patients Treated for Cancer of the Cervix
|Radiation Research|1988|397
Diabetes and Risk of Fracture
|Diabetes Care|2001|376